October 15-16, 2019 — Bethesda, MD
Event: PBOA 3rd Annual Meeting and Conference
Topic: End-User Trends & CDMO Implications

End market trends are bringing new implications for CDMOs, such as impact of curative therapies, regulatory shifts, the move to biologics, reimbursement volatility, as well patent and LOE challenges. Ian Zheng will be discussing these implications and M&A trends, and how they could relate to opportunity in the future.

Tuesday, October 15, 2019     
Bethesda North Marriott
Bethesda, MD

Time: 2:50-3:25 p.m.

About Ian Tzeng
Ian Tzeng, a Managing Director and Partner in L.E.K.’s Boston office, joined the company in 1998 with experience in growth strategy, regulated markets, innovation, pricing, and mergers and acquisitions. He focuses on healthcare and life sciences, including pharmaceuticals, vaccines and medical devices. He leads L.E.K.’s Pharmaceutical Contract Services practice, including CROs, CDMOs, supply chain and distribution, commercial, medical, and market access services. Other areas of deep experience include rare diseases, biodefense, biosimilars and generics, and consumer-directed healthcare. Additionally, Ian has extensive consulting and board experience with nonprofit organizations in education, arts, LGBT advocacy and public service.

He received a Bachelor of Arts degree, magna cum laude, in chemistry from Harvard College and is a George F. Baker Scholar, Master of Business Administration with high distinction from Harvard Business School.

PBOA 3rd Annual Meeting and Conference
At PBOA’s Annual Meeting and Conference, members are given an insider’s view of the regulatory, legislative and market trends driving the biopharmaceutical CMO/CDMO industry. These and other issues are addressed by leading industry experts and policy organizations with unique insights and impacts on the CMO/CDMO industry.

About L.E.K. Consulting
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private- and public-sector organizations, private equity firms, and emerging entrepreneurial businesses. Founded in 1983, L.E.K. employs more than 1,400 professionals across the Americas, Asia-Pacific and Europe. For more information, go to www.lek.com.